Recent noteworthy reports on diffuse large B-cell lymphoma (DLBCL) include positive survival results with an antibody-drug ...

New clinical trials are advancing treatments for cutaneous T-cell lymphoma, advanced solid tumors, pediatric sarcomas and ALK-positive lung cancer. Recent progress in cancer research is driving new ...

Turning tumors into a vaccine. Non-Hodgkin’s lymphoma (NHL) is a unique cancer that originates in the white blood cells of the human bone marrow. It is the seventh most common cancer in the United ...

Lonza said on Tuesday the first patient has been treated with a cell therapy made in its "Cocoon" platform, which the Swiss contract drug maker hopes catches on at medical centers aiming to boost use ...

—Tycel Phillips, MD, hematologist/oncologist at City of Hope Duarte Cancer Center in California walks through what to consider when treating these patients. (2:03 ...

Graphical abstract of the research findings, including key features of the three subtypes C1, C2 and C3.Graphical abstract of the research findings, including key features of the three subtypes C1, C2 ...